| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |